Debiopharm International is a highly focused company that develops drugs and therapies with a view to bringing novel biopharmaceuticals to market. The business strategy is to create partnerships for the in-licensing of biologics and small molecules from biotechnology and pharmaceutical companies as well as academic institutions worldwide.
Lead the Pharmaceutical Development department to ensure the development and manufacturing of products tailored to the needs of patients

Presentation Title: Antibody Drug Conjugates: Panorama, perspectives and manufacturing challenges

Abstract: In his presentation, Olivier will share the outstanding evolution of the Antibody Drug Conjugates field in the last decades. Reaching therapeutic success for patients with these potent anti-tumor molecules is a long journey including challenges in the manufacturing processes and in the supply chain. Trends and new directions for ADCs will be presented.

View company profile